The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: risperdal consta     Quarter: 2016Q3

Total Records: 310     Number of Pages: 16

DRUGNAME PT EventCount
RISPERDAL CONSTA Tardive dyskinesia 2
RISPERDAL CONSTA Therapeutic response decreased 2
RISPERDAL CONSTA Torticollis 2
RISPERDAL CONSTA Total cholesterol/HDL ratio increased 2
RISPERDAL CONSTA Unevaluable event 2
RISPERDAL CONSTA Urinary incontinence 2
RISPERDAL CONSTA Ventricular hypokinesia 2
RISPERDAL CONSTA Abdominal injury 1
RISPERDAL CONSTA Alopecia 1
RISPERDAL CONSTA Anxiety disorder 1
RISPERDAL CONSTA Asthma 1
RISPERDAL CONSTA Blood creatine phosphokinase increased 1
RISPERDAL CONSTA Blood testosterone decreased 1
RISPERDAL CONSTA Body height decreased 1
RISPERDAL CONSTA Breast pain 1
RISPERDAL CONSTA Breast swelling 1
RISPERDAL CONSTA Bronchitis chronic 1
RISPERDAL CONSTA Bulimia nervosa 1
RISPERDAL CONSTA Chest pain 1
RISPERDAL CONSTA Chronic obstructive pulmonary disease 1

Total Records: 310     Number of Pages: 16